An immunologist shares tips from a team-based environment

Novartis works tirelessly with third-party organizations to improve access to cancer care.

Learn how Novartis is using technology to improve the oncology clinical trial process.

Most people have never heard of spinal muscular atrophy (SMA), a rare genetic disease that affects approximately 1 in 6,000 babies born worldwide each year. Innovative research may produce treatments for patients suffering from SMA and other rare diseases.

Researchers focus on reversing the scarring that’s common to liver diseases.

Novartis collaborates with the Banner Alzheimer’s Institute to test treatments for preventing Alzheimer’s disease.

Blocking an inflammatory pathway may offer a new way to treat autoimmune disease.

Dr. Matchaba describes how his unique background can help guide the company’s access-to-medicine efforts.

Great progress has been made against malaria, but signs of resistance are becoming a rising concern

Collaborations are driving advances in sickle cell disease research, bringing new hope to patients.